2USN image
Deposition Date 1998-06-09
Release Date 1998-12-23
Last Version Date 2024-05-22
Entry Detail
PDB ID:
2USN
Keywords:
Title:
CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
H 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:STROMELYSIN-1
Gene (Uniprot):MMP3
Chain IDs:A
Chain Length:165
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
Protein Sci. 7 2118 2126 (1998)
PMID: 9792098

Abstact

The binding of two 5-substituted-1,3,4-thiadiazole-2-thione inhibitors to the matrix metalloproteinase stromelysin (MMP-3) have been characterized by protein crystallography. Both inhibitors coordinate to the catalytic zinc cation via an exocyclic sulfur and lay in an unusual position across the unprimed (P1-P3) side of the proteinase active site. Nitrogen atoms in the thiadiazole moiety make specific hydrogen bond interactions with enzyme structural elements that are conserved across all enzymes in the matrix metalloproteinase class. Strong hydrophobic interactions between the inhibitors and the side chain of tyrosine-155 appear to be responsible for the very high selectivity of these inhibitors for stromelysin. In these enzyme/inhibitor complexes, the S1' enzyme subsite is unoccupied. A conformational rearrangement of the catalytic domain occurs that reveals an inherent flexibility of the substrate binding region leading to speculation about a possible mechanism for modulation of stromelysin activity and selectivity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures